BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19244517)

  • 1. Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
    Joshi PR; Wu NP; André VM; Cummings DM; Cepeda C; Joyce JA; Carroll JB; Leavitt BR; Hayden MR; Levine MS; Bamford NS
    J Neurosci; 2009 Feb; 29(8):2414-27. PubMed ID: 19244517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.
    Kolodziejczyk K; Raymond LA
    Neurobiol Dis; 2016 Feb; 86():62-74. PubMed ID: 26621114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
    Cepeda C; Hurst RS; Calvert CR; Hernández-Echeagaray E; Nguyen OK; Jocoy E; Christian LJ; Ariano MA; Levine MS
    J Neurosci; 2003 Feb; 23(3):961-9. PubMed ID: 12574425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
    Buren C; Parsons MP; Smith-Dijak A; Raymond LA
    Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
    Parievsky A; Moore C; Kamdjou T; Cepeda C; Meshul CK; Levine MS
    Neurobiol Dis; 2017 Dec; 108():29-44. PubMed ID: 28757327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.
    Schmidt ME; Buren C; Mackay JP; Cheung D; Dal Cengio L; Raymond LA; Hayden MR
    BMC Biol; 2018 Jun; 16(1):58. PubMed ID: 29945611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overinhibition of corticostriatal activity following prenatal cocaine exposure.
    Wang W; Nitulescu I; Lewis JS; Lemos JC; Bamford IJ; Posielski NM; Storey GP; Phillips PE; Bamford NS
    Ann Neurol; 2013 Mar; 73(3):355-69. PubMed ID: 23225132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
    Laforet GA; Sapp E; Chase K; McIntyre C; Boyce FM; Campbell M; Cadigan BA; Warzecki L; Tagle DA; Reddy PH; Cepeda C; Calvert CR; Jokel ES; Klapstein GJ; Ariano MA; Levine MS; DiFiglia M; Aronin N
    J Neurosci; 2001 Dec; 21(23):9112-23. PubMed ID: 11717344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
    Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
    Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.
    Wu N; Cepeda C; Zhuang X; Levine MS
    J Neurophysiol; 2007 Jul; 98(1):423-32. PubMed ID: 17522168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.
    Milnerwood AJ; Raymond LA
    J Physiol; 2007 Dec; 585(Pt 3):817-31. PubMed ID: 17947312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.
    Cowan CM; Fan MM; Fan J; Shehadeh J; Zhang LY; Graham RK; Hayden MR; Raymond LA
    J Neurosci; 2008 Nov; 28(48):12725-35. PubMed ID: 19036965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease.
    Höhn S; Dallérac G; Faure A; Urbach YK; Nguyen HP; Riess O; von Hörsten S; Le Blanc P; Desvignes N; El Massioui N; Brown BL; Doyère V
    J Neurosci; 2011 Jun; 31(24):8986-97. PubMed ID: 21677182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The corticostriatal pathway in Huntington's disease.
    Cepeda C; Wu N; André VM; Cummings DM; Levine MS
    Prog Neurobiol; 2007 Apr; 81(5-6):253-71. PubMed ID: 17169479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential electrophysiological changes in striatal output neurons in Huntington's disease.
    André VM; Cepeda C; Fisher YE; Huynh M; Bardakjian N; Singh S; Yang XW; Levine MS
    J Neurosci; 2011 Jan; 31(4):1170-82. PubMed ID: 21273402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
    Graham RK; Pouladi MA; Joshi P; Lu G; Deng Y; Wu NP; Figueroa BE; Metzler M; André VM; Slow EJ; Raymond L; Friedlander R; Levine MS; Leavitt BR; Hayden MR
    J Neurosci; 2009 Feb; 29(7):2193-204. PubMed ID: 19228972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
    Barry J; Akopian G; Cepeda C; Levine MS
    J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington disease.
    Kolodziejczyk K; Parsons MP; Southwell AL; Hayden MR; Raymond LA
    PLoS One; 2014; 9(4):e94562. PubMed ID: 24728353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease.
    Dorner JL; Miller BR; Klein EL; Murphy-Nakhnikian A; Andrews RL; Barton SJ; Rebec GV
    Brain Res; 2009 Sep; 1290():111-20. PubMed ID: 19616518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.